Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aveo appoints CFO

This article was originally published in Scrip

Executive Summary

Cambridge, Massachusetts-based Aveo Oncology has appointed Keith S Ehrlich chief financial officer. Mr Ehrlich will be responsible for the company's financial and administrative strategy and management, and will serve on the executive leadership team. He will report to Michael Bailey, Aveo's president and CEO. Mr Ehrlich was most recently CFO of Synta Pharmaceuticals. Prior to Synta, he held various senior finance and audit roles, including CFO of Argentys, Dyax and OraVax, director of finance of Vertex Pharmaceuticals and senior audit manager with PricewaterhouseCooper.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC028507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel